Esr1tm2.1Cmet
Targeted Allele Detail
|
Symbol: |
Esr1tm2.1Cmet |
Name: |
estrogen receptor 1 (alpha); targeted mutation 2.1, Ciara Metcalfe |
MGI ID: |
MGI:7481982 |
Synonyms: |
Esr1loxP.Y541S |
Gene: |
Esr1 Location: Chr10:4561989-4955633 bp, + strand Genetic Position: Chr10, 2.03 cM
|
Alliance: |
Esr1tm2.1Cmet page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:335552
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
|
Allele Type: |
|
Targeted (Conditional ready, No functional change) |
Mutation: |
|
Insertion
|
|
|
Mutation details: A wild-type Esr1 exon 10 cDNA, followed by a 4x polyadenylation signal, an FRT-flanked PGK-neomycin selection marker, a second loxP site, and a mutated exon 10 containing a tyrosine to serine substitution at amino acid 541 (p.Y542S) replaced exon 10. The PGK-neomycin cassette was removed via flp-mediated recombinase. This corresponds to Y537S, one of the most commonly occurring human ESR1 mutations. Cre-mediated recombination is necessary to remove the wild-type exon 10 and allow expression of the modified exon 10.
(J:335552)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Esr1 Mutation: |
67 strains or lines available
|
|
Original: |
J:335552 Liang J, et al., Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer. Sci Transl Med. 2022 Sep 21;14(663):eabo5959 |
All: |
1 reference(s) |
|